MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Eye movement"

  • 2019 International Congress

    Rare causes of Opsoclonus Myoclonus Ataxia Syndrome

    A. Venkitachalam, N. Chaudhary (Mumbai, India)

    Objective: To evaluate for rare causes of Opsoclonus Myoclonus Ataxia Syndrome. Background: Opsoclonus Myoclonus is a rare acute onset neurological disorder characterized by associated ocular,…
  • 2019 International Congress

    Comparison of high versus low frequency subthalamic stimulation on eye movement

    MG. Ghilardi, L. Stock, C. Kruger-Zechlin, Z. Deeb, E. Fonoff, L. Timmermann, J. Waldthaler (Sao Paulo, Brazil)

    Objective: Compare the effects of subthalamic stimulation using high versus low frequency on saccadic and antisaccadic eye movements of idiopathic PD patients. Background: Parkinson’s disease…
  • 2019 International Congress

    GBA and ATP13A mutation and PD: clinical phenotype, eye movements and pathogenic implications

    GM. Riboldi, J. Martone, J. Rucker, JR. Rizzo, T. Hudson, W. Dauer, S. Frucht (New York, NY, USA)

    Objective: To characterize a patient with GBAand ATP13A2gene mutations. Background: Mutations of GBA(Glucocerebrosidase) and ATP13A2(P5-ATPase) genes are risk factors for Parkinson’s disease (PD). Homozygous mutations…
  • 2019 International Congress

    Use of directional stimulation to localize and troubleshoot STN-related contralateral gaze deviation: a case report

    C. Stahl, C. Cho, A. Mogilner, M. Pourfar (New York, NY, USA)

    Objective: To report a case in which STN stimulation-induced gaze deviation was mapped and managed using directional lead programming. Background: Deep Brain Stimulation (DBS) of…
  • 2019 International Congress

    A case of Aceruloplasminemia with vertical saccadic eye movement abnormalities

    O. Dogu, N. öksüz, H. Kaleagasi (Mersin, Turkey)

    Objective: We describe the phenotype, video-oculagraphic  and neuroradiological findings of a case of aceruloplasminemia (AC). Background: Aceruloplasminemia presents in adulthood and is characterized by microcytic…
  • 2018 International Congress

    Is chronic ocular motor dysfunction in syndrome of antiGAD antibody reversible with immune therapy?

    A. Mook, S. Gunzler, G. Wilmot, A. Shaikh (Cleveland, OH, USA)

    Objective: Is chronic ocular motor dysfunction in syndrome of antiGAD antibody reversible with immune therapy? Background: Increased serum titers of antiGAD antibody can be seen…
  • 2018 International Congress

    Oculomotor Behavior in Healthy Caribbean: Does it reflect an increased vulnerability to degenerative Parkinsonism?

    A. Lannuzel, A. Lackmy, B. Tressières, R. Edragas, V. Pélonde-Erimée, C. Bonnet, S. Rivaud-Péchoux, E. Roze, B. Gaymard (Pointe-à-Pitre, Guadeloupe)

    Objective: To investigate the impact of environmental factors on eye movement performances in two populations composed of carefully selected healthy subjects with strikingly different ethnic…
  • 2018 International Congress

    Update on Convergence Spasm: Review of Psychogenic and Organic Case Reports

    R. Fekete, S. Jankovic (Valhalla, NY, USA)

    Objective: The aim is to evaluate case reports and series of convergence spasm (CS). Background: CS consists of episodes of convergence of the eyes, miosis,…
  • 2018 International Congress

    Using saccades as an early test of levodopa treatment in Parkinson’s Disease

    Z.J. Lu, S. Dillon, P. Zetegren, M. Brzezick, C. Kennard, J. FitzGerald, C. (Oxford, United Kingdom)

    Objective: It is important to know what potential confounding effects the medications used to treat Parkinson’s disease (PD) have on eye movement, in order to…
  • 2018 International Congress

    Eye tracking in patients with restless legs syndrome with and without augmentation – interim results of an ongoing study

    P. Ellmerer, B. Heim, M. Ritter, A. Stefani, E. Brandauer, E. Holzknecht, K. Seppi, B. Högl, W. Poewe, A. Djamshidian (Innsbruck, Austria)

    Objective: To assess the ability to inhibit eye movements towards a target by analysing antisaccades using an eye tracker. Background: Restless legs syndrome (RLS) is…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley